In addition, GFPT2 has been associated with poor prognosis and high glucose uptake in cells of mesenchymal origin, i.e., in cancer-associated fibroblasts in lung adenocarcinoma14, but the activation of GFPT2 has not been investigated in mesenchymal tumors. The gene discussed is GFPT2; the disease is cancer.